Osteopetrosis rescue upon RANKL administration to Rankl-/- mice: A new therapy for human RANKL-dependent ARO

Journal of Bone and Mineral Research

Volumn 27, Issue 12, 2012, Pages 2501-2510

  Lo Iacono, Nadia ^a,b   Blair, Harry C ^c   Poliani, Pietro L ^d   Marrella, Veronica ^a,b   Ficara, Francesca ^a,b   Cassani, Barbara ^a,b   Facchetti, Fabio ^d   Fontana, Elena ^d   Guerrini, Matteo M ^a,b   Traggiai, Elisabetta ^e   Schena, Francesca ^b   Paulis, Marianna ^a,b   Mantero, Stefano ^a,b   Inforzato, Antonio ^b   Valaperta, Serenella ^b   Pangrazio, Alessandra ^a,b   Crisafulli, Laura ^b   Maina, Virginia ^b   Kostenuik, Paul ^f   Vezzoni, Paolo ^a,b   Villa, Anna ^a,b   Sobacchi, Cristina ^a,b   more..

^a CNR   (Italy)

^b HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d UNIVERSITY OF BRESCIA   (Italy)

^e G GASLINI INSTITUTE   (Italy)

^f AMGEN INC   (United States)

Author keywords

BONE; HEMATOLYMPHOID COMPARTMENT; OSTEOPETROSIS; RANKL; THERAPY

Indexed keywords

OSTEOCLAST DIFFERENTIATION FACTOR;

ALBERS SCHOENBERG DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOSOMAL RECESSIVE OSTEOPETROSIS; CONTROLLED STUDY; FEMALE; MALE; MOUSE; NONHUMAN; OSTEOPOROSIS; PHENOTYPE; SPLEEN; THYMUS;

EID: 84869479567     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.1712     Document Type: Article

References (30)

1. Gerritsen EJ, Vossen JM, Fasth A, Friedrich W, Morgan G, Padmos A, Vellodi A, Porras O, O'Meara A, Porta F, Bordigoni P, Cant A, Hermans J, Griscelli C, Fischer A., Bone marrow transplantation for autosomal recessive osteopetrosis. A report from the Working Party on Inborn Errors of the European Bone Marrow Transplantation Group. J Pediatr. 1994; 125: 896-902.
2. Driessen GJ, Gerritsen EJA, Fischer A, Fasth A, Hop WCJ, Veys P, Porta F, Cant A, Steward CG, Vossen JM, Uckan D, Friedrich W., Long-term outcome of haematopoietic stem cell transplantation in autosomal recessive osteopetrosis: an EBMT report. Bone Marrow Transplant. 2003; 32: 657-63.
3. Tolar J, Bonfim C, Grewal S, Orchard P., Engraftment and survival following hematopoietic stem cell transplantation for osteopetrosis using a reduced intensity conditioning regimen. Bone Marrow Transplant. 2006; 38: 783-7.
4. Mazzolari E, Forino C, Razza A, Porta F, Villa A, Notarangelo LD., A single-center experience in 20 patients with infantile malignant osteopetrosis. Am J Hematol. 2009; 84: 473-9.
5. Villa A, Guerrini MM, Cassani B, Pangrazio A, Sobacchi C., Infantile malignant, autosomal recessive osteopetrosis: the rich and the poor. Calcif Tissue Int. 2009; 84: 1-12.
6. Sobacchi C, Frattini A, Guerrini MM, Abinun M, Pangrazio A, Susani L, Bredius R, Mancini G, Cant A, Bishop N, Grabowski P, Del Fattore A, Messina C, Errigo G, Coxon FP, Scott DI, Teti A, Rogers MJ, Vezzoni P, Villa A, Helfrich MH., Osteoclast-poor human osteopetrosis due to mutations in RANKL. Nat Genet. 2007; 39: 960-2.
7. Nakashima T, Hayashi M, Fukunaga T, Kurata K, Oh-hora M, Feng JQ, Bonewald LF, Kodama T, Wutz A, Wagner EF, Penninger JM, Takayanagi H., Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat Med. 2011; 17: 1231-4.
8. Xiong J, Onal M, Jilka RL, Weinstein RS, Manolagas SC, O'Brien CA., Matrix-embedded cells control osteoclast formation. Nat Med. 2011; 17: 1235-41.
9. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ., Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 1998; 93: 165-76.
10. Burgess TL, Qian Y, Kaufman S, Ring BD, Van G, Capparelli C, Kelley M, Hsu H, Boyle WJ, Dunstan CR, Hu S, Lacey DL., The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts. J Cell Biol. 1999; 145: 527-38.
11. Lacey DL, Tan HL, Lu J, Kaufman S, Van G, Qiu W, Rattan A, Scully S, Fletcher F, Juan T, Kelley M, Burgess TL, Boyle WJ, Polverino AJ., Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo. Am J Pathol. 2000; 157: 435-48.
12. Lloyd SA, Yuan YY, Kostenuik PJ, Ominsky MS, Lau AG, Morony S, Stolina M, Asuncion FJ, Bateman TA., Soluble RANKL induces high bone turnover and decreases bone volume, density, and strength in mice. Calcif Tissue Int. 2008; 82: 361-72.
13. Shinohara M, Koga T, Okamoto K, Sakaguchi S, Arai K, Yasuda H, Takai T, Kodama T, Morio T, Geha RS, Kitamura D, Kurosaki T, Ellmeier W, Takayanagi H., Tyrosine kinases Btk and Tec regulate osteoclast differentiation by linking RANK and ITAM signals. Cell. 2008; 132: 794-806.
14. Tomimori Y, Mori K, Koide M, Nakamichi Y, Ninomiya T, Udagawa N, Yasuda H., Evaluation of pharmaceuticals with a novel 50-hour animal model of bone loss. J Bone Miner Res. 2009; 24: 1194-205.
15. Campbell GM, Ominsky MS, Boyd SK., Bone quality is partially recovered after the discontinuation of RANKL administration in rats by increased bone mass on existing trabeculae: an in vivo micro-CT study. Osteoporos Int. 2011; 22: 931-42.
16. Kim N, Odgren PR, Kim DK, Marks SC Jr, Choi Y., Diverse roles of the tumor necrosis factor family member TRANCE in skeletal physiology revealed by TRANCE deficiency and partial rescue by a lymphocyte-expressed TRANCE transgene. Proc Natl Acad Sci U S A. 2000; 97: 10905-10.
17. Tondelli B, Blair HC, Guerrini M, Patrene KD, Cassani B, Vezzoni P, Lucchini F., Fetal liver cells transplanted in utero rescue the osteopetrotic phenotype in the oc/oc mouse. Am J Pathol. 2009; 174: 727-35.
18. Marrella V, Poliani PL, Casati A, Rucci F, Frascoli L, Gougeon ML, Lemercier B, Bosticardo M, Ravanini M, Battaglia M, Roncarolo MG, Cavazzana-Calvo M, Facchetti F, Notarangelo LD, Vezzoni P, Grassi F, Villa A., A hypomorphic R229Q Rag2 mouse mutant recapitulates human Omenn syndrome. J Clin Invest. 2007; 117: 1260-9.
19. Bouxsein ML, Boyd SK, Christiansen BA, Guldberg RE, Jepsen KJ, Müller R., Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res. 2010; 25: 1468-86.
20. Ficara F, Murphy MJ, Lin M, Cleary ML., Pbx1 regulates self-renewal of long-term hematopoietic stem cells by maintaining their quiescence. Cell Stem Cell. 2008; 2: 484-96.
21. Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C, Morony S, Oliveira-dos-Santos AJ, Van G, Itie A, Khoo W, Wakeham A, Dunstan CR, Lacey DL, Mak TW, Boyle WJ, Penninger JM., OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature. 1999; 397: 315-23.
22. +CD3- inducer cells regulate development of Aire-expressing epithelial cells in the thymic medulla. J Exp Med. 2007; 204: 1267-72.
23. Hikosaka Y, Nitta T, Ohigashi I, Yano K, Ishimaru N, Hayashi Y, Matsumoto M, Matsuo K, Penninger JM, Takayanagi H, Yokota Y, Yamada H, Yoshikai Y, Inoue JI, Akiyama T, Takahama Y., The cytokine RANKL produced by positively selected thymocytes fosters medullary thymic epithelial cells that express autoimmune regulator. Immunity. 2008; 29: 438-50.
24. Fischer A, Hacein-Bey-Abina S, Cavazzana-Calvo M., Gene therapy for primary adaptive immune deficiencies. J Allergy Clin Immunol. 2011; 127: 1356-9.
25. Philippart C, Arys A, Dourov N., Effects of bone marrow transplantation on impacted dental germs in osteopetrotic op/op rats. J Oral Pathol Med. 1989; 18: 163-6.
26. Frattini A, Blair HC, Sacco MG, Cerisoli F, Faggioli F, Cate EM, Pangrazio A, Musio A, Rucci F, Sobacchi C, Sharrow AC, Kalla SE, Bruzzone MG, Colombo R, Magli MC, Vezzoni P, Villa A., Rescue of ATPa3-deficient murine malignant osteopetrosis by hematopoietic stem cell transplantation in utero. Proc Natl Acad Sci U S A. 2005; 102: 14629-34.
27. Johansson MK, de Vries TJ, Schoenmaker T, Ehinger M, Brun AC, Fasth A, Karlsson S, Everts V, Richter J., Hematopoietic stem cell-targeted neonatal gene therapy reverses lethally progressive osteopetrosis in oc/oc mice. Blood. 2007; 109: 5178-85.
28. Jälevik B, Fasth A, Dahllöf G., Dental development after successful treatment of infantile osteopetrosis with bone marrow transplantation. Bone Marrow Transplant. 2002; 29: 537-40.
29. Luzzi V, Consoli G, Daryanani V, Santoro G, Sfasciotti GL, Polimeni A., Malignant infantile osteopetrosis: dental effects in pediatric patients. Case reports. Eur J Paediatr Dent. 2006; 7: 39-44.
30. da Silva Santos PS, Esperidião AP, de Freitas R., Maxillofacial aspects in malignant osteopetrosis. Cleft Palate Craniofac J. 2009; 46: 388-90.